MG
GMDA

Michael Gelband’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Michael Gelband’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,600
Closed -$81K – 2787
2021
Q2 		$81K Buy
+12,600
New +$86.9K ﹤0.01% 2178

Other funds holding GMDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Michael Gelband's GMDA Position: Q3 2021 in Review

Michael Gelband sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q3 2021, closing a stake of 12,600 shares — an estimated $81K sold.

Michael Gelband first reported a position in GMDA in Q2 2021 and held it in 1 quarter. The position peaked at $81K in Q2 2021. 73 funds tracked by Wall St. Rank hold GMDA as of Q3 2021.

  • Michael Gelband reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Michael Gelband sold 12,600 Gamida Cell Ltd. Ordinary Shares shares in Q3 2021, an estimated $81K.
  • Michael Gelband first reported a position in Gamida Cell Ltd. Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • Michael Gelband's Gamida Cell Ltd. Ordinary Shares position peaked at $81K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.